• Home
  • News
    • Editorial
    • MD(e)B(unker)
    • Related Researches
      • Di Bella's Foundation
      • 1960-1969
      • 1970-1979
      • 1980-1989
      • 1990-1999
      • 2000-2009
      • 2010-2019
      • 2020-2029
    • Science news
    • Scientific Documentation
  • About us...
    • Biography
    • Bibliography
  • The Method
    • Di Bella's Method!
    • 1998 Trial!
  • Media
    • Video Publications
    • News-PapersNews-Papers
      • Press
    • TestimonialTestimonial
      • Testimonies
    • Video GalleryVideo Gallery
      • Congresses
      • Video Testimonies
      • TV & C.
  • Case History
    • Medical reports
      • Lung
      • Lymphomas
        • Non-Hodgkin Lymphomas
        • Hodgkin Lymphomas
      • Mediastinum
      • Mesothelioma
      • Myeloma
      • Pancreas
      • Scientific Publications
  • F.A.Q.
  • Useful Links
    • User Side
      • Vademecum
    • CouponChief - Resources for Cancer Patients
  • Contact Us
Home page   News  
Title Created Date
Why you should not use the journal impact factor to evaluate research 12 January 2014
Declaration recommends eliminate the use of Impact factor for research evaluation 10 January 2014
Display # 

Search

Follow us...

Latest

  • Radioprotective effect of melatonin against radiotherapy-induced cerebral cortex and cerebellum damage in rat
  • Radiobiological comparison of flattening filter (FF) and flattening filter-free (FFF) beam in rat laryngeal tissue
  • First Case of Regression of Carcinoid Heart Disease on Serial Transthoracic Echocardiograms following Octreotide Monotherapy in a Patient with Metastatic Pancreatic Neuroendocrine Tumor
  • Somatostatin Receptor Expression in Renal Cell Carcinoma-A New Front in the Diagnostics and Treatment of Renal Cell Carcinoma
  • Somatostatin receptor 2 expression in nasopharyngeal cancer is induced by Epstein Barr virus infection: impact on prognosis, imaging and therapy
  • Somatostatin and somatostatin analogues reduce PDGF-induced endometrial cell proliferation and motility
  • Somatostatin Analogs in Clinical Practice: a Review
  • Radioprotective effect of a combination of melatonin and metformin on mice spermatogenesis: A histological study
  • Melatonin role in the mitochondrial function
  • Melatonin Mitigates Mitochondrial Meltdown: Interactions with SIRT3
  • Melatonin in mitochondrial dysfunction and related disorders
  • Melatonin: A Mitochondrial Targeting Molecule Involving Mitochondrial Protection and Dynamics
  • The Radioprotective Effect of Combination of Melatonin and Metformin on Rat Duodenum Damage Induced by Ionizing Radiation: A Histological Study
  • Preventive and curative effect of melatonin on mammary carcinogenesis induced by dimethylbenz[a]anthracene in the female Sprague-Dawley rat
  • Octreotide and pasireotide effects on medullary thyroid carcinoma (MTC) cells growth, migration and invasion
  • Melatonin synthesis in and uptake by mitochondria: implications for diseased cells with dysfunctional mitochondria
  • Melatonin provides protection against cisplatin-induced ovarian damage and loss of fertility in mice
  • Melatonin protects against cisplatin-induced ovarian damage in mice via the MT1 receptor and antioxidant activity

Most Read

  • The Di Bella Method (DBM)
  • All-trans-retinoic acid and cancer
  • About melatonin - 1996
  • Biography
  • The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
  • Bibliography
  • Somatostatin in oncology, the overlooked evidences
  • Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
  • Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
  • Vademecum
  • Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
  • Frequently Asked Questions
  • How effective is chemo therapy?
  • Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
  • Complete objective response to biological therapy of plurifocal breast carcinoma
  • Declaration recommends eliminate the use of Impact factor for research evaluation
  • Malignant pleural mesothelioma, stage T3-T4 - Consideration of a case study
  • The melatonin deception